SS&C Technologies director sells $1.44 million in company stock

SS&C Technologies Holdings Inc (NASDAQ:SSNC) director Michael J. Zamkow has sold a significant portion of his holdings in the company, according to the latest regulatory filings. The transactions, which took place on September 20, 2024, involved the sale of 19,000 shares of common stock at an average price of $75.9704 per share, amounting to a total of approximately $1.44 million.

The sale was executed at varying prices within the range of $75.78 to $76.015, as detailed in the filing. Following the sale, Zamkow still retains a total of 22,576 shares directly, which reflects his continued stake in the company's success. Additionally, he holds an indirect interest in 2,175 shares through a brokerage account in the name of his adult son and 46,200 shares through family trusts. It should be noted that Zamkow disclaims beneficial ownership of the securities held indirectly, except to the extent of his pecuniary interest.

This transaction comes as part of the regular financial disclosures made by company insiders, providing transparency to the market and allowing investors to see the trading activities of senior executives and directors. SS&C Technologies, a leading provider of services and software for the financial services industry, has not provided any specific reason for Zamkow's sale of shares.

Investors often monitor insider transactions as they may provide insights into the executives' perspectives on the company's current valuation and future prospects. However, such transactions can be motivated by a variety of personal financial considerations and should not be taken as a sole indicator of a company's performance.

The stock market, including individual investors and larger institutional stakeholders, keeps a close watch on these filings to better understand the movements within the company's leadership and their confidence in the firm's trajectory. SS&C Technologies' shares remain a point of interest as market participants digest the implications of this recent insider activity.



In other recent news, SS&C Technologies Holdings, Inc. has seen significant developments in its financial performance and strategic growth initiatives. The company's second quarter 2024 results exceeded expectations, with organic revenue growth of 6.4% and an adjusted diluted earnings per share increase of 17.6% year-over-year. In a strategic move, SS&C has entered into an agreement to acquire Battea-Class Action Services for approximately $670 million, which is expected to enhance its financial recovery services.

Analysts from RBC Capital and Needham have revised their outlook on SS&C, raising their price targets while maintaining positive ratings. The raised targets are a reflection of the company's strong financial performance and the expected benefits from the upcoming Battea acquisition. In addition, SS&C's Board of Directors has approved an increase in the company's quarterly dividend from $0.24 to $0.25 per share, following reported growth in net cash from operating activities.

These recent developments underline SS&C's robust financial health and commitment to strategic growth. The company's initiatives, like the acquisition of Battea and the increase in dividend, are expected to contribute positively to its future performance. However, these developments do not represent a comprehensive view of the company's financial health or future performance.
InvestingPro Insights


SS&C Technologies Holdings Inc (NASDAQ:SSNC) has exhibited a stable financial performance with several positive indicators that may interest investors. According to InvestingPro data, SSNC boasts a market capitalization of $18.39 billion, reflecting its substantial presence in the industry. The company's P/E ratio stands at 26.42, indicating investors' valuation of its earnings. Furthermore, SSNC has shown a gross profit margin of 49.38% in the last twelve months as of Q2 2024, underscoring its efficiency in managing costs relative to revenue.

InvestingPro Tips highlight that SS&C Technologies has raised its dividend for 7 consecutive years, showcasing a commitment to returning value to shareholders. Additionally, analysts predict that the company will be profitable this year, which aligns with the company's track record of profitability over the last twelve months. These factors, combined with SSNC's 11-year history of maintaining dividend payments, could signal a reliable investment for those looking for steady income and long-term growth.

For investors seeking more nuanced analysis, InvestingPro offers additional tips on SSNC, accessible through the InvestingPro platform. There are 11 more InvestingPro Tips available, which provide deeper insights into the company's financial health and market position.

As the market processes the recent insider sale by director Michael J. Zamkow, these InvestingPro Insights may offer a broader context to understand SS&C Technologies' financial standing and future potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com

Последние публикации
Roivant Sciences executive sells shares worth over $2.9 million
25.09.2024 - 05:00
Alco Investment Co buys Banzai International shares worth over $1m
25.09.2024 - 05:00
Roivant Sciences CEO sells over $23 million in company stock
25.09.2024 - 05:00
Endeavor Group CEO sells over $4.9 million in class A stock
25.09.2024 - 05:00
Viant Technology CFO Larry Madden sells over $77k in company stock
25.09.2024 - 05:00
Power solutions insider sells over $1.1m in company stock
25.09.2024 - 05:00
Palantir Technologies Inc. sells shares in Surf Air Mobility
25.09.2024 - 04:00
US stock futures steady after Nvidia pushes Wall St to record highs
25.09.2024 - 04:00
Country Garden Services to sell stake in Zhuhai Wanda for $446 million
25.09.2024 - 04:00
Zscaler director Brown sells shares worth over $1.39 million
25.09.2024 - 04:00
Edgewise Therapeutics CMO sells $202k in company stock
25.09.2024 - 04:00
Edgewise Therapeutics general counsel sells over $1.9m in company stock
25.09.2024 - 04:00
Edgewise Therapeutics CFO sells over $3.5 million in company stock
25.09.2024 - 04:00
Edgewise Therapeutics executive sells over $1.2m in stock
25.09.2024 - 04:00
Edgewise Therapeutics CSO sells over $2 million in company stock
25.09.2024 - 04:00

© Analytic DC. All Rights Reserved.

new
Обзор рынка Потребительские настроения в США снизились в сентябре
Добро пожаловать в чат поддержки!
*
*

Ваш запрос успешно отправлен!
Скоро с вами свяжутся.